Global Rabies Immune Globulin Market Research Report 2023
Rabies immunoglobulin (RIG) is a medication made up of antibodies against the rabies virus. It is used to prevent rabies following exposure.
According to QYResearch’s new survey, global Rabies Immune Globulin market is projected to reach US$ 694.4 million in 2029, increasing from US$ 424 million in 2022, with the CAGR of 7.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rabies Immune Globulin market research.
The Rabies Immune Globulin market is driven by the critical need to prevent and treat rabies infections effectively. Rabies immune globulin (RIG) is a key component of post-exposure prophylaxis, providing passive immunity against the virus. The increased awareness of rabies' potential severity, particularly in regions with higher prevalence rates, propels market growth. Additionally, the rising number of travelers and potential exposure to rabies in endemic areas contribute to demand. However, challenges include the limited availability of RIG in certain regions and the high cost associated with its production and administration. Ensuring timely access to RIG, especially in remote or resource-constrained areas, and addressing potential allergic reactions or adverse events are ongoing concerns. The market's success depends on the collaboration between healthcare systems and regulatory bodies to ensure sufficient availability, proper distribution, and affordability of rabies immune globulin, ultimately reducing the global burden of this deadly disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rabies Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Rabies Immune Globulin market is projected to reach US$ 694.4 million in 2029, increasing from US$ 424 million in 2022, with the CAGR of 7.3% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Rabies Immune Globulin market research.
The Rabies Immune Globulin market is driven by the critical need to prevent and treat rabies infections effectively. Rabies immune globulin (RIG) is a key component of post-exposure prophylaxis, providing passive immunity against the virus. The increased awareness of rabies' potential severity, particularly in regions with higher prevalence rates, propels market growth. Additionally, the rising number of travelers and potential exposure to rabies in endemic areas contribute to demand. However, challenges include the limited availability of RIG in certain regions and the high cost associated with its production and administration. Ensuring timely access to RIG, especially in remote or resource-constrained areas, and addressing potential allergic reactions or adverse events are ongoing concerns. The market's success depends on the collaboration between healthcare systems and regulatory bodies to ensure sufficient availability, proper distribution, and affordability of rabies immune globulin, ultimately reducing the global burden of this deadly disease.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Rabies Immune Globulin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- CSL Behring
- Grifols
- Sanofi
- Sichuan Yuanda Shuyang
- CNBG
- Kamada
- CBPO
- Shuanglin Bio
- Weiguang Bio
- Shanghai RAAS
- Bharat Serum
- VINS
- ERIG
- HRIG
- Category II Exposure
- Category III Exposure
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 RABIES IMMUNE GLOBULIN MARKET OVERVIEW
1.1 Product Overview and Scope of Rabies Immune Globulin
1.2 Rabies Immune Globulin Segment by Type
1.2.1 Global Rabies Immune Globulin Market Value Comparison by Type (2023-2029)
1.2.2 ERIG
1.2.3 HRIG
1.3 Rabies Immune Globulin Segment by Application
1.3.1 Global Rabies Immune Globulin Market Value by Application: (2023-2029)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Rabies Immune Globulin Market Size Estimates and Forecasts
1.4.1 Global Rabies Immune Globulin Revenue 2018-2029
1.4.2 Global Rabies Immune Globulin Sales 2018-2029
1.4.3 Global Rabies Immune Globulin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 RABIES IMMUNE GLOBULIN MARKET COMPETITION BY MANUFACTURERS
2.1 Global Rabies Immune Globulin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rabies Immune Globulin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rabies Immune Globulin Average Price by Manufacturers (2018-2023)
2.4 Global Rabies Immune Globulin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rabies Immune Globulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rabies Immune Globulin, Product Type & Application
2.7 Rabies Immune Globulin Market Competitive Situation and Trends
2.7.1 Rabies Immune Globulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rabies Immune Globulin Players Market Share by Revenue
2.7.3 Global Rabies Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RABIES IMMUNE GLOBULIN RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Rabies Immune Globulin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rabies Immune Globulin Global Rabies Immune Globulin Sales by Region: 2018-2029
3.2.1 Global Rabies Immune Globulin Sales by Region: 2018-2023
3.2.2 Global Rabies Immune Globulin Sales by Region: 2024-2029
3.3 Global Rabies Immune Globulin Global Rabies Immune Globulin Revenue by Region: 2018-2029
3.3.1 Global Rabies Immune Globulin Revenue by Region: 2018-2023
3.3.2 Global Rabies Immune Globulin Revenue by Region: 2024-2029
3.4 North America Rabies Immune Globulin Market Facts & Figures by Country
3.4.1 North America Rabies Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rabies Immune Globulin Sales by Country (2018-2029)
3.4.3 North America Rabies Immune Globulin Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rabies Immune Globulin Market Facts & Figures by Country
3.5.1 Europe Rabies Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rabies Immune Globulin Sales by Country (2018-2029)
3.5.3 Europe Rabies Immune Globulin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rabies Immune Globulin Market Facts & Figures by Country
3.6.1 Asia Pacific Rabies Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rabies Immune Globulin Sales by Country (2018-2029)
3.6.3 Asia Pacific Rabies Immune Globulin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rabies Immune Globulin Market Facts & Figures by Country
3.7.1 Latin America Rabies Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rabies Immune Globulin Sales by Country (2018-2029)
3.7.3 Latin America Rabies Immune Globulin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rabies Immune Globulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Rabies Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rabies Immune Globulin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rabies Immune Globulin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Rabies Immune Globulin Sales by Type (2018-2029)
4.1.1 Global Rabies Immune Globulin Sales by Type (2018-2023)
4.1.2 Global Rabies Immune Globulin Sales by Type (2024-2029)
4.1.3 Global Rabies Immune Globulin Sales Market Share by Type (2018-2029)
4.2 Global Rabies Immune Globulin Revenue by Type (2018-2029)
4.2.1 Global Rabies Immune Globulin Revenue by Type (2018-2023)
4.2.2 Global Rabies Immune Globulin Revenue by Type (2024-2029)
4.2.3 Global Rabies Immune Globulin Revenue Market Share by Type (2018-2029)
4.3 Global Rabies Immune Globulin Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Rabies Immune Globulin Sales by Application (2018-2029)
5.1.1 Global Rabies Immune Globulin Sales by Application (2018-2023)
5.1.2 Global Rabies Immune Globulin Sales by Application (2024-2029)
5.1.3 Global Rabies Immune Globulin Sales Market Share by Application (2018-2029)
5.2 Global Rabies Immune Globulin Revenue by Application (2018-2029)
5.2.1 Global Rabies Immune Globulin Revenue by Application (2018-2023)
5.2.2 Global Rabies Immune Globulin Revenue by Application (2024-2029)
5.2.3 Global Rabies Immune Globulin Revenue Market Share by Application (2018-2029)
5.3 Global Rabies Immune Globulin Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CSL Behring Rabies Immune Globulin Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Grifols Rabies Immune Globulin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Rabies Immune Globulin Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Sichuan Yuanda Shuyang
6.4.1 Sichuan Yuanda Shuyang Corporation Information
6.4.2 Sichuan Yuanda Shuyang Description and Business Overview
6.4.3 Sichuan Yuanda Shuyang Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sichuan Yuanda Shuyang Rabies Immune Globulin Product Portfolio
6.4.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.5 CNBG
6.5.1 CNBG Corporation Information
6.5.2 CNBG Description and Business Overview
6.5.3 CNBG Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CNBG Rabies Immune Globulin Product Portfolio
6.5.5 CNBG Recent Developments/Updates
6.6 Kamada
6.6.1 Kamada Corporation Information
6.6.2 Kamada Description and Business Overview
6.6.3 Kamada Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Kamada Rabies Immune Globulin Product Portfolio
6.6.5 Kamada Recent Developments/Updates
6.7 CBPO
6.6.1 CBPO Corporation Information
6.6.2 CBPO Description and Business Overview
6.6.3 CBPO Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CBPO Rabies Immune Globulin Product Portfolio
6.7.5 CBPO Recent Developments/Updates
6.8 Shuanglin Bio
6.8.1 Shuanglin Bio Corporation Information
6.8.2 Shuanglin Bio Description and Business Overview
6.8.3 Shuanglin Bio Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Shuanglin Bio Rabies Immune Globulin Product Portfolio
6.8.5 Shuanglin Bio Recent Developments/Updates
6.9 Weiguang Bio
6.9.1 Weiguang Bio Corporation Information
6.9.2 Weiguang Bio Description and Business Overview
6.9.3 Weiguang Bio Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Weiguang Bio Rabies Immune Globulin Product Portfolio
6.9.5 Weiguang Bio Recent Developments/Updates
6.10 Shanghai RAAS
6.10.1 Shanghai RAAS Corporation Information
6.10.2 Shanghai RAAS Description and Business Overview
6.10.3 Shanghai RAAS Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai RAAS Rabies Immune Globulin Product Portfolio
6.10.5 Shanghai RAAS Recent Developments/Updates
6.11 Bharat Serum
6.11.1 Bharat Serum Corporation Information
6.11.2 Bharat Serum Rabies Immune Globulin Description and Business Overview
6.11.3 Bharat Serum Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Bharat Serum Rabies Immune Globulin Product Portfolio
6.11.5 Bharat Serum Recent Developments/Updates
6.12 VINS
6.12.1 VINS Corporation Information
6.12.2 VINS Rabies Immune Globulin Description and Business Overview
6.12.3 VINS Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.12.4 VINS Rabies Immune Globulin Product Portfolio
6.12.5 VINS Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Rabies Immune Globulin Industry Chain Analysis
7.2 Rabies Immune Globulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rabies Immune Globulin Production Mode & Process
7.4 Rabies Immune Globulin Sales and Marketing
7.4.1 Rabies Immune Globulin Sales Channels
7.4.2 Rabies Immune Globulin Distributors
7.5 Rabies Immune Globulin Customers
8 RABIES IMMUNE GLOBULIN MARKET DYNAMICS
8.1 Rabies Immune Globulin Industry Trends
8.2 Rabies Immune Globulin Market Drivers
8.3 Rabies Immune Globulin Market Challenges
8.4 Rabies Immune Globulin Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Rabies Immune Globulin
1.2 Rabies Immune Globulin Segment by Type
1.2.1 Global Rabies Immune Globulin Market Value Comparison by Type (2023-2029)
1.2.2 ERIG
1.2.3 HRIG
1.3 Rabies Immune Globulin Segment by Application
1.3.1 Global Rabies Immune Globulin Market Value by Application: (2023-2029)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Rabies Immune Globulin Market Size Estimates and Forecasts
1.4.1 Global Rabies Immune Globulin Revenue 2018-2029
1.4.2 Global Rabies Immune Globulin Sales 2018-2029
1.4.3 Global Rabies Immune Globulin Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 RABIES IMMUNE GLOBULIN MARKET COMPETITION BY MANUFACTURERS
2.1 Global Rabies Immune Globulin Sales Market Share by Manufacturers (2018-2023)
2.2 Global Rabies Immune Globulin Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Rabies Immune Globulin Average Price by Manufacturers (2018-2023)
2.4 Global Rabies Immune Globulin Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Rabies Immune Globulin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Rabies Immune Globulin, Product Type & Application
2.7 Rabies Immune Globulin Market Competitive Situation and Trends
2.7.1 Rabies Immune Globulin Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Rabies Immune Globulin Players Market Share by Revenue
2.7.3 Global Rabies Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RABIES IMMUNE GLOBULIN RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Rabies Immune Globulin Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Rabies Immune Globulin Global Rabies Immune Globulin Sales by Region: 2018-2029
3.2.1 Global Rabies Immune Globulin Sales by Region: 2018-2023
3.2.2 Global Rabies Immune Globulin Sales by Region: 2024-2029
3.3 Global Rabies Immune Globulin Global Rabies Immune Globulin Revenue by Region: 2018-2029
3.3.1 Global Rabies Immune Globulin Revenue by Region: 2018-2023
3.3.2 Global Rabies Immune Globulin Revenue by Region: 2024-2029
3.4 North America Rabies Immune Globulin Market Facts & Figures by Country
3.4.1 North America Rabies Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Rabies Immune Globulin Sales by Country (2018-2029)
3.4.3 North America Rabies Immune Globulin Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Rabies Immune Globulin Market Facts & Figures by Country
3.5.1 Europe Rabies Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Rabies Immune Globulin Sales by Country (2018-2029)
3.5.3 Europe Rabies Immune Globulin Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Rabies Immune Globulin Market Facts & Figures by Country
3.6.1 Asia Pacific Rabies Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Rabies Immune Globulin Sales by Country (2018-2029)
3.6.3 Asia Pacific Rabies Immune Globulin Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Rabies Immune Globulin Market Facts & Figures by Country
3.7.1 Latin America Rabies Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Rabies Immune Globulin Sales by Country (2018-2029)
3.7.3 Latin America Rabies Immune Globulin Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Rabies Immune Globulin Market Facts & Figures by Country
3.8.1 Middle East and Africa Rabies Immune Globulin Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Rabies Immune Globulin Sales by Country (2018-2029)
3.8.3 Middle East and Africa Rabies Immune Globulin Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Rabies Immune Globulin Sales by Type (2018-2029)
4.1.1 Global Rabies Immune Globulin Sales by Type (2018-2023)
4.1.2 Global Rabies Immune Globulin Sales by Type (2024-2029)
4.1.3 Global Rabies Immune Globulin Sales Market Share by Type (2018-2029)
4.2 Global Rabies Immune Globulin Revenue by Type (2018-2029)
4.2.1 Global Rabies Immune Globulin Revenue by Type (2018-2023)
4.2.2 Global Rabies Immune Globulin Revenue by Type (2024-2029)
4.2.3 Global Rabies Immune Globulin Revenue Market Share by Type (2018-2029)
4.3 Global Rabies Immune Globulin Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Rabies Immune Globulin Sales by Application (2018-2029)
5.1.1 Global Rabies Immune Globulin Sales by Application (2018-2023)
5.1.2 Global Rabies Immune Globulin Sales by Application (2024-2029)
5.1.3 Global Rabies Immune Globulin Sales Market Share by Application (2018-2029)
5.2 Global Rabies Immune Globulin Revenue by Application (2018-2029)
5.2.1 Global Rabies Immune Globulin Revenue by Application (2018-2023)
5.2.2 Global Rabies Immune Globulin Revenue by Application (2024-2029)
5.2.3 Global Rabies Immune Globulin Revenue Market Share by Application (2018-2029)
5.3 Global Rabies Immune Globulin Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.1.4 CSL Behring Rabies Immune Globulin Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Corporation Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Grifols Rabies Immune Globulin Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Rabies Immune Globulin Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Sichuan Yuanda Shuyang
6.4.1 Sichuan Yuanda Shuyang Corporation Information
6.4.2 Sichuan Yuanda Shuyang Description and Business Overview
6.4.3 Sichuan Yuanda Shuyang Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sichuan Yuanda Shuyang Rabies Immune Globulin Product Portfolio
6.4.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.5 CNBG
6.5.1 CNBG Corporation Information
6.5.2 CNBG Description and Business Overview
6.5.3 CNBG Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.5.4 CNBG Rabies Immune Globulin Product Portfolio
6.5.5 CNBG Recent Developments/Updates
6.6 Kamada
6.6.1 Kamada Corporation Information
6.6.2 Kamada Description and Business Overview
6.6.3 Kamada Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Kamada Rabies Immune Globulin Product Portfolio
6.6.5 Kamada Recent Developments/Updates
6.7 CBPO
6.6.1 CBPO Corporation Information
6.6.2 CBPO Description and Business Overview
6.6.3 CBPO Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CBPO Rabies Immune Globulin Product Portfolio
6.7.5 CBPO Recent Developments/Updates
6.8 Shuanglin Bio
6.8.1 Shuanglin Bio Corporation Information
6.8.2 Shuanglin Bio Description and Business Overview
6.8.3 Shuanglin Bio Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Shuanglin Bio Rabies Immune Globulin Product Portfolio
6.8.5 Shuanglin Bio Recent Developments/Updates
6.9 Weiguang Bio
6.9.1 Weiguang Bio Corporation Information
6.9.2 Weiguang Bio Description and Business Overview
6.9.3 Weiguang Bio Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Weiguang Bio Rabies Immune Globulin Product Portfolio
6.9.5 Weiguang Bio Recent Developments/Updates
6.10 Shanghai RAAS
6.10.1 Shanghai RAAS Corporation Information
6.10.2 Shanghai RAAS Description and Business Overview
6.10.3 Shanghai RAAS Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai RAAS Rabies Immune Globulin Product Portfolio
6.10.5 Shanghai RAAS Recent Developments/Updates
6.11 Bharat Serum
6.11.1 Bharat Serum Corporation Information
6.11.2 Bharat Serum Rabies Immune Globulin Description and Business Overview
6.11.3 Bharat Serum Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Bharat Serum Rabies Immune Globulin Product Portfolio
6.11.5 Bharat Serum Recent Developments/Updates
6.12 VINS
6.12.1 VINS Corporation Information
6.12.2 VINS Rabies Immune Globulin Description and Business Overview
6.12.3 VINS Rabies Immune Globulin Sales, Revenue and Gross Margin (2018-2023)
6.12.4 VINS Rabies Immune Globulin Product Portfolio
6.12.5 VINS Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Rabies Immune Globulin Industry Chain Analysis
7.2 Rabies Immune Globulin Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Rabies Immune Globulin Production Mode & Process
7.4 Rabies Immune Globulin Sales and Marketing
7.4.1 Rabies Immune Globulin Sales Channels
7.4.2 Rabies Immune Globulin Distributors
7.5 Rabies Immune Globulin Customers
8 RABIES IMMUNE GLOBULIN MARKET DYNAMICS
8.1 Rabies Immune Globulin Industry Trends
8.2 Rabies Immune Globulin Market Drivers
8.3 Rabies Immune Globulin Market Challenges
8.4 Rabies Immune Globulin Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Rabies Immune Globulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Rabies Immune Globulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Rabies Immune Globulin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Rabies Immune Globulin Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Rabies Immune Globulin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Rabies Immune Globulin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Rabies Immune Globulin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Rabies Immune Globulin Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Rabies Immune Globulin, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Rabies Immune Globulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rabies Immune Globulin, Product Type & Application
Table 12. Global Key Manufacturers of Rabies Immune Globulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rabies Immune Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rabies Immune Globulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Rabies Immune Globulin Sales by Region (2018-2023) & (K Units)
Table 18. Global Rabies Immune Globulin Sales Market Share by Region (2018-2023)
Table 19. Global Rabies Immune Globulin Sales by Region (2024-2029) & (K Units)
Table 20. Global Rabies Immune Globulin Sales Market Share by Region (2024-2029)
Table 21. Global Rabies Immune Globulin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Rabies Immune Globulin Revenue Market Share by Region (2018-2023)
Table 23. Global Rabies Immune Globulin Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Rabies Immune Globulin Revenue Market Share by Region (2024-2029)
Table 25. North America Rabies Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Rabies Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 27. North America Rabies Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 28. North America Rabies Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Rabies Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Rabies Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Rabies Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 32. Europe Rabies Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 33. Europe Rabies Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Rabies Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Rabies Immune Globulin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Rabies Immune Globulin Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Rabies Immune Globulin Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Rabies Immune Globulin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Rabies Immune Globulin Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Rabies Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Rabies Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Rabies Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Rabies Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Rabies Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Rabies Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Rabies Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Rabies Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Rabies Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Rabies Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Rabies Immune Globulin Sales (K Units) by Type (2018-2023)
Table 51. Global Rabies Immune Globulin Sales (K Units) by Type (2024-2029)
Table 52. Global Rabies Immune Globulin Sales Market Share by Type (2018-2023)
Table 53. Global Rabies Immune Globulin Sales Market Share by Type (2024-2029)
Table 54. Global Rabies Immune Globulin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Rabies Immune Globulin Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Rabies Immune Globulin Revenue Market Share by Type (2018-2023)
Table 57. Global Rabies Immune Globulin Revenue Market Share by Type (2024-2029)
Table 58. Global Rabies Immune Globulin Price (US$/Unit) by Type (2018-2023)
Table 59. Global Rabies Immune Globulin Price (US$/Unit) by Type (2024-2029)
Table 60. Global Rabies Immune Globulin Sales (K Units) by Application (2018-2023)
Table 61. Global Rabies Immune Globulin Sales (K Units) by Application (2024-2029)
Table 62. Global Rabies Immune Globulin Sales Market Share by Application (2018-2023)
Table 63. Global Rabies Immune Globulin Sales Market Share by Application (2024-2029)
Table 64. Global Rabies Immune Globulin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Rabies Immune Globulin Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Rabies Immune Globulin Revenue Market Share by Application (2018-2023)
Table 67. Global Rabies Immune Globulin Revenue Market Share by Application (2024-2029)
Table 68. Global Rabies Immune Globulin Price (US$/Unit) by Application (2018-2023)
Table 69. Global Rabies Immune Globulin Price (US$/Unit) by Application (2024-2029)
Table 70. CSL Behring Corporation Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. CSL Behring Rabies Immune Globulin Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Grifols Corporation Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Grifols Rabies Immune Globulin Product
Table 79. Grifols Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi Rabies Immune Globulin Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Sichuan Yuanda Shuyang Corporation Information
Table 86. Sichuan Yuanda Shuyang Description and Business Overview
Table 87. Sichuan Yuanda Shuyang Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Sichuan Yuanda Shuyang Rabies Immune Globulin Product
Table 89. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 90. CNBG Corporation Information
Table 91. CNBG Description and Business Overview
Table 92. CNBG Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. CNBG Rabies Immune Globulin Product
Table 94. CNBG Recent Developments/Updates
Table 95. Kamada Corporation Information
Table 96. Kamada Description and Business Overview
Table 97. Kamada Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Kamada Rabies Immune Globulin Product
Table 99. Kamada Recent Developments/Updates
Table 100. CBPO Corporation Information
Table 101. CBPO Description and Business Overview
Table 102. CBPO Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. CBPO Rabies Immune Globulin Product
Table 104. CBPO Recent Developments/Updates
Table 105. Shuanglin Bio Corporation Information
Table 106. Shuanglin Bio Description and Business Overview
Table 107. Shuanglin Bio Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Shuanglin Bio Rabies Immune Globulin Product
Table 109. Shuanglin Bio Recent Developments/Updates
Table 110. Weiguang Bio Corporation Information
Table 111. Weiguang Bio Description and Business Overview
Table 112. Weiguang Bio Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Weiguang Bio Rabies Immune Globulin Product
Table 114. Weiguang Bio Recent Developments/Updates
Table 115. Shanghai RAAS Corporation Information
Table 116. Shanghai RAAS Description and Business Overview
Table 117. Shanghai RAAS Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Shanghai RAAS Rabies Immune Globulin Product
Table 119. Shanghai RAAS Recent Developments/Updates
Table 120. Bharat Serum Corporation Information
Table 121. Bharat Serum Description and Business Overview
Table 122. Bharat Serum Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Bharat Serum Rabies Immune Globulin Product
Table 124. Bharat Serum Recent Developments/Updates
Table 125. VINS Corporation Information
Table 126. VINS Description and Business Overview
Table 127. VINS Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. VINS Rabies Immune Globulin Product
Table 129. VINS Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Rabies Immune Globulin Distributors List
Table 133. Rabies Immune Globulin Customers List
Table 134. Rabies Immune Globulin Market Trends
Table 135. Rabies Immune Globulin Market Drivers
Table 136. Rabies Immune Globulin Market Challenges
Table 137. Rabies Immune Globulin Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 1. Global Rabies Immune Globulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Rabies Immune Globulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Rabies Immune Globulin Market Competitive Situation by Manufacturers in 2022
Table 4. Global Rabies Immune Globulin Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Rabies Immune Globulin Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Rabies Immune Globulin Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Rabies Immune Globulin Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Rabies Immune Globulin Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Rabies Immune Globulin, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Rabies Immune Globulin, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Rabies Immune Globulin, Product Type & Application
Table 12. Global Key Manufacturers of Rabies Immune Globulin, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Rabies Immune Globulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rabies Immune Globulin as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Rabies Immune Globulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Rabies Immune Globulin Sales by Region (2018-2023) & (K Units)
Table 18. Global Rabies Immune Globulin Sales Market Share by Region (2018-2023)
Table 19. Global Rabies Immune Globulin Sales by Region (2024-2029) & (K Units)
Table 20. Global Rabies Immune Globulin Sales Market Share by Region (2024-2029)
Table 21. Global Rabies Immune Globulin Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Rabies Immune Globulin Revenue Market Share by Region (2018-2023)
Table 23. Global Rabies Immune Globulin Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Rabies Immune Globulin Revenue Market Share by Region (2024-2029)
Table 25. North America Rabies Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Rabies Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 27. North America Rabies Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 28. North America Rabies Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Rabies Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Rabies Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Rabies Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 32. Europe Rabies Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 33. Europe Rabies Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Rabies Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Rabies Immune Globulin Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Rabies Immune Globulin Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Rabies Immune Globulin Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Rabies Immune Globulin Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Rabies Immune Globulin Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Rabies Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Rabies Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Rabies Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Rabies Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Rabies Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Rabies Immune Globulin Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Rabies Immune Globulin Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Rabies Immune Globulin Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Rabies Immune Globulin Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Rabies Immune Globulin Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Rabies Immune Globulin Sales (K Units) by Type (2018-2023)
Table 51. Global Rabies Immune Globulin Sales (K Units) by Type (2024-2029)
Table 52. Global Rabies Immune Globulin Sales Market Share by Type (2018-2023)
Table 53. Global Rabies Immune Globulin Sales Market Share by Type (2024-2029)
Table 54. Global Rabies Immune Globulin Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Rabies Immune Globulin Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Rabies Immune Globulin Revenue Market Share by Type (2018-2023)
Table 57. Global Rabies Immune Globulin Revenue Market Share by Type (2024-2029)
Table 58. Global Rabies Immune Globulin Price (US$/Unit) by Type (2018-2023)
Table 59. Global Rabies Immune Globulin Price (US$/Unit) by Type (2024-2029)
Table 60. Global Rabies Immune Globulin Sales (K Units) by Application (2018-2023)
Table 61. Global Rabies Immune Globulin Sales (K Units) by Application (2024-2029)
Table 62. Global Rabies Immune Globulin Sales Market Share by Application (2018-2023)
Table 63. Global Rabies Immune Globulin Sales Market Share by Application (2024-2029)
Table 64. Global Rabies Immune Globulin Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Rabies Immune Globulin Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Rabies Immune Globulin Revenue Market Share by Application (2018-2023)
Table 67. Global Rabies Immune Globulin Revenue Market Share by Application (2024-2029)
Table 68. Global Rabies Immune Globulin Price (US$/Unit) by Application (2018-2023)
Table 69. Global Rabies Immune Globulin Price (US$/Unit) by Application (2024-2029)
Table 70. CSL Behring Corporation Information
Table 71. CSL Behring Description and Business Overview
Table 72. CSL Behring Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. CSL Behring Rabies Immune Globulin Product
Table 74. CSL Behring Recent Developments/Updates
Table 75. Grifols Corporation Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Grifols Rabies Immune Globulin Product
Table 79. Grifols Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Sanofi Rabies Immune Globulin Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Sichuan Yuanda Shuyang Corporation Information
Table 86. Sichuan Yuanda Shuyang Description and Business Overview
Table 87. Sichuan Yuanda Shuyang Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Sichuan Yuanda Shuyang Rabies Immune Globulin Product
Table 89. Sichuan Yuanda Shuyang Recent Developments/Updates
Table 90. CNBG Corporation Information
Table 91. CNBG Description and Business Overview
Table 92. CNBG Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. CNBG Rabies Immune Globulin Product
Table 94. CNBG Recent Developments/Updates
Table 95. Kamada Corporation Information
Table 96. Kamada Description and Business Overview
Table 97. Kamada Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Kamada Rabies Immune Globulin Product
Table 99. Kamada Recent Developments/Updates
Table 100. CBPO Corporation Information
Table 101. CBPO Description and Business Overview
Table 102. CBPO Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. CBPO Rabies Immune Globulin Product
Table 104. CBPO Recent Developments/Updates
Table 105. Shuanglin Bio Corporation Information
Table 106. Shuanglin Bio Description and Business Overview
Table 107. Shuanglin Bio Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Shuanglin Bio Rabies Immune Globulin Product
Table 109. Shuanglin Bio Recent Developments/Updates
Table 110. Weiguang Bio Corporation Information
Table 111. Weiguang Bio Description and Business Overview
Table 112. Weiguang Bio Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Weiguang Bio Rabies Immune Globulin Product
Table 114. Weiguang Bio Recent Developments/Updates
Table 115. Shanghai RAAS Corporation Information
Table 116. Shanghai RAAS Description and Business Overview
Table 117. Shanghai RAAS Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Shanghai RAAS Rabies Immune Globulin Product
Table 119. Shanghai RAAS Recent Developments/Updates
Table 120. Bharat Serum Corporation Information
Table 121. Bharat Serum Description and Business Overview
Table 122. Bharat Serum Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Bharat Serum Rabies Immune Globulin Product
Table 124. Bharat Serum Recent Developments/Updates
Table 125. VINS Corporation Information
Table 126. VINS Description and Business Overview
Table 127. VINS Rabies Immune Globulin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. VINS Rabies Immune Globulin Product
Table 129. VINS Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Rabies Immune Globulin Distributors List
Table 133. Rabies Immune Globulin Customers List
Table 134. Rabies Immune Globulin Market Trends
Table 135. Rabies Immune Globulin Market Drivers
Table 136. Rabies Immune Globulin Market Challenges
Table 137. Rabies Immune Globulin Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Rabies Immune Globulin
Figure 2. Global Rabies Immune Globulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Rabies Immune Globulin Market Share by Type in 2022 & 2029
Figure 4. ERIG Product Picture
Figure 5. HRIG Product Picture
Figure 6. Global Rabies Immune Globulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Rabies Immune Globulin Market Share by Application in 2022 & 2029
Figure 8. Category II Exposure
Figure 9. Category III Exposure
Figure 10. Global Rabies Immune Globulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Rabies Immune Globulin Market Size (2018-2029) & (US$ Million)
Figure 12. Global Rabies Immune Globulin Sales (2018-2029) & (K Units)
Figure 13. Global Rabies Immune Globulin Average Price (US$/Unit) & (2018-2029)
Figure 14. Rabies Immune Globulin Report Years Considered
Figure 15. Rabies Immune Globulin Sales Share by Manufacturers in 2022
Figure 16. Global Rabies Immune Globulin Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Rabies Immune Globulin Players: Market Share by Revenue in 2022
Figure 18. Rabies Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Rabies Immune Globulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Rabies Immune Globulin Sales Market Share by Country (2018-2029)
Figure 21. North America Rabies Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 22. United States Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Rabies Immune Globulin Sales Market Share by Country (2018-2029)
Figure 25. Europe Rabies Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 26. Germany Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Rabies Immune Globulin Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Rabies Immune Globulin Revenue Market Share by Region (2018-2029)
Figure 33. China Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Rabies Immune Globulin Sales Market Share by Country (2018-2029)
Figure 43. Latin America Rabies Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Rabies Immune Globulin Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Rabies Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Rabies Immune Globulin by Type (2018-2029)
Figure 53. Global Revenue Market Share of Rabies Immune Globulin by Type (2018-2029)
Figure 54. Global Rabies Immune Globulin Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Rabies Immune Globulin by Application (2018-2029)
Figure 56. Global Revenue Market Share of Rabies Immune Globulin by Application (2018-2029)
Figure 57. Global Rabies Immune Globulin Price (US$/Unit) by Application (2018-2029)
Figure 58. Rabies Immune Globulin Value Chain
Figure 59. Rabies Immune Globulin Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Figure 1. Product Picture of Rabies Immune Globulin
Figure 2. Global Rabies Immune Globulin Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Rabies Immune Globulin Market Share by Type in 2022 & 2029
Figure 4. ERIG Product Picture
Figure 5. HRIG Product Picture
Figure 6. Global Rabies Immune Globulin Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Rabies Immune Globulin Market Share by Application in 2022 & 2029
Figure 8. Category II Exposure
Figure 9. Category III Exposure
Figure 10. Global Rabies Immune Globulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Rabies Immune Globulin Market Size (2018-2029) & (US$ Million)
Figure 12. Global Rabies Immune Globulin Sales (2018-2029) & (K Units)
Figure 13. Global Rabies Immune Globulin Average Price (US$/Unit) & (2018-2029)
Figure 14. Rabies Immune Globulin Report Years Considered
Figure 15. Rabies Immune Globulin Sales Share by Manufacturers in 2022
Figure 16. Global Rabies Immune Globulin Revenue Share by Manufacturers in 2022
Figure 17. The Global 5 and 10 Largest Rabies Immune Globulin Players: Market Share by Revenue in 2022
Figure 18. Rabies Immune Globulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 19. Global Rabies Immune Globulin Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 20. North America Rabies Immune Globulin Sales Market Share by Country (2018-2029)
Figure 21. North America Rabies Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 22. United States Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 23. Canada Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Europe Rabies Immune Globulin Sales Market Share by Country (2018-2029)
Figure 25. Europe Rabies Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 26. Germany Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. France Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. U.K. Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Italy Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Russia Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Asia Pacific Rabies Immune Globulin Sales Market Share by Region (2018-2029)
Figure 32. Asia Pacific Rabies Immune Globulin Revenue Market Share by Region (2018-2029)
Figure 33. China Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Japan Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. South Korea Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. India Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Australia Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. China Taiwan Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Indonesia Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Thailand Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Malaysia Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Rabies Immune Globulin Sales Market Share by Country (2018-2029)
Figure 43. Latin America Rabies Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Rabies Immune Globulin Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Rabies Immune Globulin Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Rabies Immune Globulin Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Rabies Immune Globulin by Type (2018-2029)
Figure 53. Global Revenue Market Share of Rabies Immune Globulin by Type (2018-2029)
Figure 54. Global Rabies Immune Globulin Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Rabies Immune Globulin by Application (2018-2029)
Figure 56. Global Revenue Market Share of Rabies Immune Globulin by Application (2018-2029)
Figure 57. Global Rabies Immune Globulin Price (US$/Unit) by Application (2018-2029)
Figure 58. Rabies Immune Globulin Value Chain
Figure 59. Rabies Immune Globulin Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
